Robert Rifkin, MD from Rocky Mountain Cancer Center discusses survival and depth of response in African American and Non-AA patients and conflicting data on the virulence of myeloma for African American patients at the 2017 American Society of Hematology.
Survival and Depth of Response in African American and Non-AA Patients – Conflicting data on the virulence of Myeloma for African American patients
By Editor